Stay updated on NSCLC Progressed Anti-PD-1 Clinical Trial
Sign up to get notified when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.
Latest updates to the NSCLC Progressed Anti-PD-1 Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov record for the HUDSON Phase II NSCLC study is now displayed with its study details, participant criteria, treatment plans, outcome measures, and supporting documents.SummaryDifference100%
- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record remains unavailable on the error page.SummaryDifference0.2%
- Check17 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%
- Check24 days agoChange DetectedThe ClinicalTrials.gov page no longer displays the HUDSON lung cancer trial record and instead shows a 403 Forbidden error.SummaryDifference23%
- Check31 days agoChange DetectedThe HUDSON Phase II lung cancer trial record is available with its study design, participant criteria, outcomes, results, and supporting documents. It replaces the previously displayed access-denied error page.SummaryDifference100%
- Check52 days agoChange DetectedThe study page now shows a 403 Forbidden error, indicating the study record is blocked from access. The previous detailed content and associated documents are not accessible, with a standard error page displayed instead.SummaryDifference23%
Stay in the know with updates to NSCLC Progressed Anti-PD-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.